Keywords: neurocrine, resubmits, indiplon, nda, san, diego, california

Neurocrine resubmits indiplon NDA

Article | 03 September 2007

Print This

San Diego, California, USA-based Neurocrine Biosciences says that the Food and Drug Administration has accepted the resubmission of its New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in